Ann: Acrux Signs Licensing Agreement with Harris Pharmaceutical, page-4

seems to be heading in the right direction. I like the idea of multiple pharma partners. All our products wont be with one pharma coy if something goes amiss. Seems ACR are picking partners that have some specialty in one area. Wont help share price. Really need the Elma and Testosterone dossiers to be approved by the FDA ASAP, and the 4 dossiers earmarked for submission to the FDA by 31/12/20 to be on track. I'm thinking 3 are for Trupharma and 1 is for Amring. Also there may be another announcement as to whom the Testosterone partner is.